Literature DB >> 29181372

The new era of cancer immunotherapy: what can molecular imaging do to help?

Laura Evangelista1, Marion de Jong2, Silvana Del Vecchio3, Weibo Cai4.   

Abstract

Entities:  

Year:  2017        PMID： 29181372      PMCID： PMC5701751          DOI： 10.1007/s40336-017-0241-z

Source DB:  PubMed          Journal:  Clin Transl Imaging        ISSN： 2281-5872


× No keyword cloud information.
  9 in total

1.  Pseudoprogression and Immune-Related Response in Solid Tumors.

Authors:  Victoria L Chiou; Mauricio Burotto
Journal:  J Clin Oncol       Date:  2015-08-10       Impact factor: 44.544

2.  Noninvasive monitoring of cancer therapy induced activated T cells using [18F]FB-IL-2 PET imaging.

Authors:  S V Hartimath; O Draghiciu; S van de Wall; V Manuelli; R A J O Dierckx; H W Nijman; T Daemen; E F J de Vries
Journal:  Oncoimmunology       Date:  2016-11-18       Impact factor: 8.110

Review 3.  iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.

Authors:  Lesley Seymour; Jan Bogaerts; Andrea Perrone; Robert Ford; Lawrence H Schwartz; Sumithra Mandrekar; Nancy U Lin; Saskia Litière; Janet Dancey; Alice Chen; F Stephen Hodi; Patrick Therasse; Otto S Hoekstra; Lalitha K Shankar; Jedd D Wolchok; Marcus Ballinger; Caroline Caramella; Elisabeth G E de Vries
Journal:  Lancet Oncol       Date:  2017-03-02       Impact factor: 41.316

Review 4.  The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.

Authors:  Annie N M Wong; Grant A McArthur; Michael S Hofman; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-07       Impact factor: 9.236

5.  Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.

Authors:  Jedd D Wolchok; Axel Hoos; Steven O'Day; Jeffrey S Weber; Omid Hamid; Celeste Lebbé; Michele Maio; Michael Binder; Oliver Bohnsack; Geoffrey Nichol; Rachel Humphrey; F Stephen Hodi
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

Review 6.  Molecular Imaging of Immunotherapy Targets in Cancer.

Authors:  Emily B Ehlerding; Christopher G England; Douglas G McNeel; Weibo Cai
Journal:  J Nucl Med       Date:  2016-07-28       Impact factor: 10.057

7.  CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.

Authors:  Georg Bier; Vera Hoffmann; Christopher Kloth; Ahmed E Othman; Thomas Eigentler; Claus Garbe; Christian La Fougère; Christina Pfannenberg; Konstantin Nikolaou; Bernhard Klumpp
Journal:  Eur J Radiol       Date:  2016-01-19       Impact factor: 3.528

8.  Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy.

Authors:  Benjamin Y Kong; Alexander M Menzies; Catherine A B Saunders; Elizabeth Liniker; Sangeetha Ramanujam; Alex Guminski; Richard F Kefford; Georgina V Long; Matteo S Carlino
Journal:  Pigment Cell Melanoma Res       Date:  2016-08-04       Impact factor: 4.693

9.  Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?

Authors:  Matteo Bauckneht; Roberta Piva; Gianmario Sambuceti; Francesco Grossi; Silvia Morbelli
Journal:  World J Radiol       Date:  2017-02-28
  9 in total
  3 in total

Review 1.  Noninvasive PET Imaging of T cells.

Authors:  Weijun Wei; Dawei Jiang; Emily B Ehlerding; Quanyong Luo; Weibo Cai
Journal:  Trends Cancer       Date:  2018-04-17

2.  PET/CT and the Response to Immunotherapy in Lung Cancer.

Authors:  Laura Evangelista; Matteo Sepulcri; Giulia Pasello
Journal:  Curr Radiopharm       Date:  2020

3.  QIN Benchmarks for Clinical Translation of Quantitative Imaging Tools.

Authors:  Keyvan Farahani; Darrell Tata; Robert J Nordstrom
Journal:  Tomography       Date:  2019-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.